QQQ   416.36 (-1.67%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.36 (-1.67%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.36 (-1.67%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
QQQ   416.36 (-1.67%)
AAPL   165.22 (-1.09%)
MSFT   400.51 (-0.93%)
META   483.43 (-3.66%)
GOOGL   154.21 (-1.15%)
AMZN   174.94 (-2.39%)
TSLA   148.29 (-1.09%)
NVDA   790.23 (-6.67%)
AMD   148.29 (-4.38%)
NIO   3.83 (-4.25%)
BABA   68.94 (+0.09%)
T   16.42 (+0.55%)
F   12.12 (+0.50%)
MU   107.14 (-4.28%)
GE   148.97 (-2.60%)
CGC   7.96 (+1.66%)
DIS   112.39 (-0.04%)
AMC   3.21 (+9.93%)
PFE   25.82 (+1.69%)
PYPL   62.07 (-0.05%)
XOM   119.86 (+1.13%)
NASDAQ:BGLC

BioNexus Gene Lab (BGLC) Stock Price, News & Analysis

$0.66
-0.19 (-22.22%)
(As of 02:09 PM ET)
Today's Range
$0.59
$0.71
50-Day Range
$0.41
$1.57
52-Week Range
$0.31
$17.88
Volume
598,293 shs
Average Volume
1.29 million shs
Market Capitalization
$11.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BGLC stock logo

About BioNexus Gene Lab Stock (NASDAQ:BGLC)

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

BGLC Stock Price History

BGLC Stock News Headlines

Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?
BioNexus Gene Lab Invests in AI Healthcare Company
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
BioNexus Gene Lab Corp Common stock (BGLC)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
BGLC BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC)
Why Is BioNexus Gene Lab (BGLC) Stock Up 33% Today?
BioNexus Gene Lab Corp (BGLC)
BIONEXUS GENE LAB CORP
BioNexus Gene Lab Corp Ordinary Shares
Why Is BioNexus Gene Lab (BGLC) Stock Up 64% Today?
BGLC - BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp.
See More Headlines
Receive BGLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:BGLC
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Net Income
$-360,000.00
Pretax Margin
-28.91%

Debt

Sales & Book Value

Annual Sales
$9.77 million

Miscellaneous

Free Float
16,576,000
Market Cap
$11.74 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Su-Leng Tan (Age 40)
    CEO & Director
    Comp: $16k
  • Mr. Kwan Wah Chan
    Marketing Manager
  • Mr. Too Kam Tham
    Managing Director

BGLC Stock Analysis - Frequently Asked Questions

How have BGLC shares performed in 2024?

BioNexus Gene Lab's stock was trading at $0.53 at the start of the year. Since then, BGLC stock has increased by 24.5% and is now trading at $0.66.
View the best growth stocks for 2024 here
.

Are investors shorting BioNexus Gene Lab?

BioNexus Gene Lab saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 43,400 shares, an increase of 115.9% from the March 15th total of 20,100 shares. Based on an average trading volume of 1,440,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.6% of the company's stock are sold short.
View BioNexus Gene Lab's Short Interest
.

When is BioNexus Gene Lab's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our BGLC earnings forecast
.

When did BioNexus Gene Lab IPO?

BioNexus Gene Lab (BGLC) raised $5 million in an IPO on Thursday, July 20th 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO.

How do I buy shares of BioNexus Gene Lab?

Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BGLC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners